Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Yellow-Fruit Nightshade and Improved Peak Expiratory Flow Rate

Doses used in studies

mg/day: 300–900 (median 600, IQR 450–750) — 2 studies

Time to effect

Median: 3 days · IQR 3 days–3 days · Range 3 days–3 days — Reported in 1 of 2 studies

Safety in these studies

Overall tolerabilityReported
No untoward effects were reported during the study.
from: A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in b

2 of 2 papers

Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma.
- 2004-10
- RCT
- Phytotherapy research : PTR 18(10)
- - S Govindan
  - S Viswanathan
  - V Vijayasekaran
  - R Alagappan
- PubMed: 15551394
- DOI: 10.1002/ptr.1555
5 Insights on
- Improved Peak Expiratory Flow Rate
- High evidence
- Clinical
S. xanthocarpum and S. trilobatum produced a progressive improvement in the ventilatory function of asthmatic individuals over 3 days. The improvement in PEFR and the reduction in other symptom scores clearly indicate a bronchodilator effect
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
300 mg tds for 3 days
A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma.
- 1999-08
- Clinical Trial
- Journal of ethnopharmacology 66(2)
- - S Govindan
  - S Viswanathan
  - V Vijayasekaran
  - R Alagappan
- PubMed: 10433479
- DOI: 10.1016/s0378-8741(98)00160-3
4 Insights on
- Improved Peak Expiratory Flow Rate
- Moderate evidence
- Clinical
Treatment with either S. xanthocarpum or S. trilobatum significantly improved the various parameters of pulmonary function in asthmatic subjects.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
300 mg